揭示丁酸盐作为帕金森病治疗方法
António E Abreu1,2,3, Nuno Empadinhas1,2, Sandra Morais Cardoso4,5,6
1CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
Neuroscience bulletin
|October 15, 2025
概括
丁酸盐是一种肠道细菌产物,对肠道健康和肠-大脑轴是至关重要的. 补充丁酸盐通过减少炎症和改善肠道屏障功能,有望治疗帕金森病.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群产生丁酸盐,一种短链脂肪酸 (SCFA),对肠道平衡和肠-大脑轴至关重要.
- 失生症和SCFA不平衡与疾病发病有关,丁酸盐的减少与肠道透性,炎症和神经炎症的增加有关.
- 帕金森病 (PD) 的发病可能涉及肠道失调和SCFA变化,这表明丁酸盐具有潜在的治疗作用.
研究的目的:
- 审查丁酸盐在肠道中的起源,功能和机制.
- 在帕金森病的背景下,检查丁酸盐对肠-大脑轴的影响.
- 在PD模型和人体研究中探索Butyrate补充剂的治疗潜力.
主要方法:
- 关于丁酸盐,肠道微生物群和帕金森病的研究的文献综述.
- 分析"大脑第一"和"肠道第一"PD模型,以了解丁酸盐的相关性.
- 检查关于丁酸盐补充剂在PD中的疗效的临床前和临床数据.
主要成果:
- 丁酸盐在维持肠道屏障完整性和调节炎症反应方面发挥着重要作用.
- 降低的丁酸盐水平与神经退行性疾病如PD的进展有关.
- 丁酸盐补充剂在动物模型和PD早期人类研究中显示出潜在的益处.
结论:
- 丁酸盐是一种关键的代谢物,在帕金森病中具有治疗潜力.
- 通过丁酸盐调制准肠-大脑轴为PD管理提供了一种新的策略.
- 专注于神经和胃肠系统的综合方法对于创新的PD预防和治疗至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
931
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
931
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:21Drugs for Treatment of Constipation-Predominant IBS
664
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
664
01:17Drugs for Treatment of Diarrhea-Predominant IBS
590
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
590
01:29Inflammatory Bowel Disease IV: Pharmacological Management
427
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
427
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
447
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
447